You are here

  • Home
  • Archive
  • Volume 80, Issue 9
  • Efficacy and safety of tofacitinib versus baricitinib in patients with rheumatoid arthritis in real clinical practice: analyses with propensity score-based inverse probability of treatment weighting

Article metrics

Article menu
XML
Rheumatoid arthritis
Efficacy and safety of tofacitinib versus baricitinib in patients with rheumatoid arthritis in real clinical practice: analyses with propensity score-based inverse probability of treatment weighting

 

Online download statistics by month:

Online download statistics by month: April 2021 to March 2024

AbstractFullPdf
Apr 202117371688950
May 202118261808492
Jun 2021477468236
Jul 2021373371186
Aug 202110501046356
Sep 2021543534258
Oct 2021490483256
Nov 2021309303157
Dec 202120420689
Jan 202224624488
Feb 2022201200103
Mar 2022242234115
Apr 2022247247102
May 2022282270160
Jun 2022251246129
Jul 202218418580
Aug 202221020163
Sep 202220719870
Oct 202221521291
Nov 202219018467
Dec 202216115849
Jan 202315615255
Feb 202323622368
Mar 202321220458
Apr 202314614048
May 202317416763
Jun 202313312943
Jul 202316915342
Aug 202316615954
Sep 202318517539
Oct 202323122373
Nov 202316415335
Dec 202314913932
Jan 2024665434
Feb 202415810635
Mar 202421120381
Total12201118664857